Novelion Therapeutics Inc. (NVLN) Rose 10.68% or 0.11 To Price $1.14 On Tuesday


Novelion Therapeutics Inc. (NVLN) rose 10.68% or 0.11 to $1.14. It is around 384615 shares traded, which is 40.69% compare to the average total volume 945334. The market cap of NVLN is $21.58 million. The year to date change is 20.84%. The 52 week price range is from $0.7 to $5.87. Price of NVLN have changed 6.19% during last week. It have changed -6.36% over last month, -13.45% over last 3 months, -68.88% over last 6 months and -73.25% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NVLN is 1.00. It is -12.28% below current price. The 200-day Moving Averages for NVLN is 2.84. It is 149.12% above current price. The 52-week High is 5.87. It is 414.91% from the current price. The 52-week Low is 0.7. It is -38.60% from current price.

There are some statistics of NVLN. It is has market cap $21.58 million. The share outstanding is 18.93 million. The average volume is 945334. The percent of top 15 Institution holding is 85.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NVLN is 733.91%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NVLN is -30.95%.


Tags:

Share this post